Topical corticosteroids adherence in chronic rhinosinusitis with nasal polyps patients on dupilumab
Volume: 0 - Issue: 0
First page: 0 - Last page: 0
S.M. Miotti - C. Brühlmann - A. Yalamanoglu - U.C. Steiner - C.M. Meerwein - M.B. Soyka
DOI: 10.4193/Rhin25.102
Biologics like dupilumab have revolutionized the management of patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma (1-3). However, topical corticosteroids, such as intranasal (INCS) and inhaled (ICS) corticosteroids still play a fundamental role in the management of these conditions (4, 5). To this day, limited data is available on topical corticosteroids medication adherence combined with dupilumab in achieving CRSwNP and asthma symptom control. Considering the generally poor medication-adherence among chronic patients and the remarkable efficacy of dupilumab, we suspected low adherence to INCS and ICS (6-8).
Rhinology 0-0: 0-0, 0000
To see the issue content and the abstract you do not have to login
Please login to download the full articles
If you do not have a subscription to Rhinology please consider taking one.
